According to the SURMOUNT-1 clinical trial, patients using tirzepatide at the highest dose (15 mg weekly) experienced up to 22.5% total body weight loss over 72 weeksgreater than what is typically seen with semaglutide GLP-1
Yes, headache is a recognised adverse effect of GLP-1 receptor agonists, though it occurs less frequently than gastrointestinal symptoms
Avoid injecting into areas that are: Bruised, tender, or broken Affected by skin conditions such as psoriasis or eczema Near moles, scars, or areas of lipohypertrophy Always use a new needle for every injection and do not inject through clothing
Trimi's Terms of Service acknowledges HIPAA applicability and states that patient information is handled through their platform with security protocols
These pharmacies typically assign more conservative BUDs because they may not have the analytical resources to conduct extended stability testing on every formulation they compound
Talk to Your Prescriber About Alternatives Your licensed healthcare provider can help tailor therapy considering cost, clinical effectiveness and safety
